Corestemchemon Inc
KOSDAQ:166480
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corestemchemon Inc
KOSDAQ:166480
|
KR |
|
T
|
Tsakos Energy Navigation Ltd
F:TK41
|
GR |
Intrinsic Value
The intrinsic value of Corestemchemon Inc (166480) under the Base Case is 961.25 KRW per share. Compared with the current market price of 1 705 KRW, the stock appears Overvalued by 44% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -105% last year to 5.7% by 2033. If operating margin stayed at its five-year average of -58%, the estimate would be about ₩208. The forecast years subtract value, so the estimate rests entirely on the years after 2033.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Corestemchemon Does
Corestemchemon is a South Korean biotech company built around stem-cell and cell-culture technology. It develops and sells regenerative medicine products, related medical materials, and skin-care products that use the company’s laboratory know-how. In simple terms, it turns advanced cell research into products that can be used in hospitals, clinics, and consumer beauty channels.
- Headquarters
- Korea KR
- IPO date
- Jun 26, 2015
Revenue & Expenses Breakdown
Corestemchemon Inc
Earnings Waterfall
Corestemchemon Inc
The intrinsic value for Corestemchemon Inc (166480) under the Base Case is 961.25 KRW.
Compared with the current market price of 1 705 KRW, the stock appears Overvalued by 44% .